{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:30:50Z","timestamp":1760142650649,"version":"build-2065373602"},"reference-count":19,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1016\/j.biopha.2007.08.014","type":"journal-article","created":{"date-parts":[[2007,9,17]],"date-time":"2007-09-17T08:21:44Z","timestamp":1190017304000},"page":"553-557","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Evaluation of therapeutic efficacy of capecitabine on human breast carcinoma tissues and cell lines in vitro"],"prefix":"10.1016","volume":"61","author":[{"given":"Wings T.Y.","family":"Loo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hironobu","family":"Sasano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louis W.C.","family":"Chow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2007.08.014_bib1","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/S0959-8049(98)00058-6","article-title":"Design of a novel oral fluoropyrimidine carbamate, Capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue","volume":"34","author":"Miwa","year":"1998","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.biopha.2007.08.014_bib2","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1200\/JCO.1999.17.2.485","article-title":"Multicenter phase II study of Capecitabine in paclitaxel-refractory metastatic breast cancer","volume":"17","author":"Blum","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.biopha.2007.08.014_bib3","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1023\/A:1006497231579","article-title":"Capecitabine: preclinical pharmacology studies","volume":"18","author":"Ishitsuka","year":"2000","journal-title":"Invest New Drugs"},{"key":"10.1016\/j.biopha.2007.08.014_bib4","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1002\/cncr.21122","article-title":"Capecitabine plus docetaxel combination therapy","volume":"103","author":"Verma","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.biopha.2007.08.014_bib5","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1517\/13543784.6.12.1853","article-title":"Docetaxel: a new active agent in the therapy of metastatic breast cancer","volume":"6","author":"Fumoleau","year":"1997","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.biopha.2007.08.014_bib6","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.2165\/00003495-200565170-00007","article-title":"Docetaxel: a review of its use in metastatic breast cancer","volume":"65","author":"Lyseng-Williamson","year":"2005","journal-title":"Drugs"},{"key":"10.1016\/j.biopha.2007.08.014_bib7","first-page":"967","article-title":"Isolation of two human tumor epithelial cell lines from solid breast carcinomas","volume":"61","author":"Lasfargues","year":"1978","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.biopha.2007.08.014_bib8","first-page":"1639","article-title":"BRCA1 and BRCA2 mRNA levels are coordinately elevated in human breast cancer cells in response to estrogen","volume":"13","author":"Spillman","year":"1996","journal-title":"Oncogene"},{"key":"10.1016\/j.biopha.2007.08.014_bib9","first-page":"1441","article-title":"Steroid receptor-mediated cytotoxicity of an antiestrogen and an antiprogestin in breast cancer cells","volume":"47","author":"Bardon","year":"1987","journal-title":"Cancer Res"},{"key":"10.1016\/j.biopha.2007.08.014_bib10","first-page":"2877","article-title":"Alpha-fetoprotein derived from a human hepatoma prevents growth of estrogen-dependent human breast cancer xenografts","volume":"4","author":"Bennett","year":"1998","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.biopha.2007.08.014_bib11","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.lfs.2004.09.016","article-title":"Arimidex inhibition on proliferation of human breast solid tumors measured by ATP bioluminescence","volume":"76","author":"Tse","year":"2004","journal-title":"Life Sci"},{"key":"10.1016\/j.biopha.2007.08.014_bib12","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.lfs.2004.06.021","article-title":"The inhibitory effect of a herbal formula comprising ginseng and carthamus tinctorius on breast cancer","volume":"76","author":"Loo","year":"2004","journal-title":"Life Sci"},{"key":"10.1016\/j.biopha.2007.08.014_bib13","first-page":"7","article-title":"Modulation of apoptosis signaling pathways and cell cycle regulation","volume":"26","author":"Eastman","year":"1999","journal-title":"Semin Oncol"},{"key":"10.1016\/j.biopha.2007.08.014_bib14","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/00001813-199506000-00006","article-title":"Methotrexate chemosensitivity by ATP luminescence in human leukemia cell lines and in breast cancer primary cultures: comparison of the TCA-100 assay with a clonogenic assay","volume":"6","author":"Cree","year":"1995","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.biopha.2007.08.014_bib15","first-page":"242","article-title":"Heterogeneity of chemosensitivity in human breast carcinoma: use of an adenosine triphosphate (ATP) chemiluminescence assay","volume":"19","author":"Hunter","year":"1993","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.biopha.2007.08.014_bib16","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1055\/s-2007-1022245","article-title":"Chemosensitivity testing in gynecologic oncology. Experiences with an ATP bioluminescence assay","volume":"56","author":"Kurbacher","year":"1996","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"10.1016\/j.biopha.2007.08.014_bib17","doi-asserted-by":"crossref","first-page":"7212","DOI":"10.1200\/JCO.2005.07.501","article-title":"Proliferation marker Ki-67 in early breast cancer","volume":"23","author":"Urruticoechea","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.biopha.2007.08.014_bib18","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9","article-title":"The Ki-67 protein: from the known and the unknown","volume":"182","author":"Scholzen","year":"2000","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.biopha.2007.08.014_bib19","first-page":"923","article-title":"Transmission of apoptosis in human colorectal tumor cells exposed to capecitabine, Xeloda, is mediated via Fas","volume":"1","author":"Ciccolini","year":"2002","journal-title":"Mol Cancer Ther"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332207001849?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332207001849?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T10:39:50Z","timestamp":1760092790000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332207001849"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":19,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["S0753332207001849"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2007.08.014","relation":{},"ISSN":["0753-3322"],"issn-type":[{"type":"print","value":"0753-3322"}],"subject":[],"published":{"date-parts":[[2007,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of therapeutic efficacy of capecitabine on human breast carcinoma tissues and cell lines in vitro","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2007.08.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}